DarioHealth Corp. has announced the presentation of new research at ISPOR Europe 2025, evaluating the economic impact of its multi-condition digital health platform in employer populations. The study, titled "Preliminary Observational Analysis of Digital Health Platform Associated with Medical Cost Changes in Employer Population," analyzed medical claims data and found a significant reduction in total medical costs for employer members using Dario's platform, with the greatest effect observed among high-risk populations. These results were presented at the conference in Glasgow, Scotland, and represent DarioHealth's first publication using claims data to assess cost outcomes. The company's platform is currently used by employers, health plans, and partners across the U.S. to support chronic condition management.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN21447) on November 12, 2025, and is solely responsible for the information contained therein.
Comments